Parkwood LLC Nkarta, Inc. Transaction History

Parkwood LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.27 - $18.39 $112,515 - $168,636	-9,170 Reduced 29.21%	22,224 $292,000
Q2 2022 Aug 15, 2022	BUY	$7.77 - $19.44 $243,931 - $610,299	31,394 New	31,394 $31,000
Q4 2021 Feb 11, 2022	SELL	$12.79 - $26.88 $207,441 - $435,966	-16,219 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$26.67 - $38.76 $63,981 - $92,985	-2,399 Reduced 12.89%	16,219 $451,000
Q2 2021 Aug 13, 2021	SELL	$23.94 - $36.68 $21,450 - $32,865	-896 Reduced 4.59%	18,618 $590,000
Q1 2021 May 14, 2021	BUY	$31.33 - $59.61 $23,842 - $45,363	761 Added 4.06%	19,514 $642,000
Q4 2020 Feb 12, 2021	BUY	$27.03 - $75.62 $506,893 - $1.42 Million	18,753 New	18,753 $1.15 Million

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $119M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

Stay updated on Parkwood LLC with notifications on news.